Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice

Cabezas, JoaquínLondoño, M.C.Llerena, S.Muñoz-Gómez, R.Baliellas, CarmeButi, M.Pascasio Acevedo, Juan ManuelSáez-Royuela, F.García-Samaniego, J.Vega, J. de laSánchez-Pobre, P.Álvarez-Navascues, C.Carrión, José A.Gea, F.Morillas, R.M.Fernández-Bermejo, M.Castro-Iglesias, ÁngelesRivero, M.Fernández, J.R.Berenguer, M.Moreno, J.J.Rincón, D.Calleja-Panero, José LuisCrespo, J.2019-02-042019-02-042016Cabezas J, Londoño MC, Llerena S, et al. Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practice. En: International Liver Congress; 2017 Apr 19-23; Amsterdam, The Netherlands. Amsterdam: Elsevier; 2016. p, S779 (J Hepatol. 2016; 64 Suppl 2)0168-8278http://hdl.handle.net/2183/21654AbstractengAtribución-NoComercial-SinDerivadas 3.0 Españahttp://creativecommons.org/licenses/by-nc-nd/3.0/es/Efficacy and safety of HCV-treatment with direct-acting antiviral agents interferon-free, in patients with severe renal impairment in clinical practiceconference outputopen access